de Brabander Ellen 4

What Happened

• Ellen de Brabander, Executive Vice President, Research, Development and Regulatory Affairs at Elanco Animal Health (ELAN), received 40,985 shares as an award on 2026-04-01 (code A).
• To satisfy tax withholding related to that award (code F), 20,288 of those shares were surrendered/withheld at $23.12 per share, a withholding value of about $469,059. The award shares show an acquisition price of $0.00 (reflecting a grant/vesting).

Key Details

• Transaction date: April 1, 2026.
• Award: 40,985 shares granted (A) at $0.00 per share.
• Withholding/disposition: 20,288 shares withheld (F) at $23.12 per share; total value ≈ $469,059.
• Shares owned after the transaction: not stated in the Form 4 filing.
• Filing date: April 7, 2026 — filed six days after the reported transaction date (Form 4s are typically due within 2 business days), so this filing appears to have been submitted late.
• Note: Code F indicates shares were withheld to cover tax obligations, not an open-market sale.

Context

• This appears to be a standard equity award vesting with shares withheld to cover taxes (a routine corporate practice). The award (A) is an acquisition of stock through compensation; the withheld shares (F) are a disposition for tax purposes rather than an expression of market sentiment.
• Purchases are often more informative than awards or tax-withholding dispositions; this filing primarily documents compensation vesting and the associated tax withholding.